MTFMT Antibody (OTI2A2) [mFluor Violet 500 SE]
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-72803MFV500
Key Product Details
Species Reactivity
Human
Applications
Western Blot
Label
mFluor Violet 500 SE (Excitation = 410 nm, Emission = 501 nm)
Antibody Source
Monoclonal Mouse IgG1 Clone # OTI2A2
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
Human recombinant protein fragment corresponding to amino acids 175-389 of human MTFMT(NP_640335) produced in E.coli.
Clonality
Monoclonal
Host
Mouse
Isotype
IgG1
Applications for MTFMT Antibody (OTI2A2) [mFluor Violet 500 SE]
Application
Recommended Usage
Western Blot
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Immunogen affinity purified
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: MTFMT
Alternate Names
EC 2.1.2.9, FMT, FMT1methionyl-tRNA formyltransferase, mitochondrial, mitochondrial methionyl-tRNA formyltransferase, MtFMT
Gene Symbol
MTFMT
Additional MTFMT Products
Product Documents for MTFMT Antibody (OTI2A2) [mFluor Violet 500 SE]
Product Specific Notices for MTFMT Antibody (OTI2A2) [mFluor Violet 500 SE]
mFluor(TM) is a trademark of AAT Bioquest, Inc. This conjugate is made on demand. Actual recovery may vary from the stated volume of this product. The volume will be greater than or equal to the unit size stated on the datasheet.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...